Pain Therapeutics Conference

Explore the possibilities of DNA-based, disease modifying treatments for painful diabetic neuropathy with ViroMed | Overcome the challenges of patient recruitment and the placebo response with Novartis | Learn how AstraZeneca and Eli Lilly are targeting ion channels to reduce pain | Get involved in round table discussions on chronic pain and depression, the opioid crisis, and alternatives to animal models | Listen to Centrexion, Amgen, Janssen, Nektar Therapeutics and Grunenthal discuss the current industry outlook | The upcoming Pain Therapeutics conference moves away from well discussed topics such as opioid dependence and animal models and focuses on the most exciting current research, opinions, novel targets and mechanisms and advances in the field of analgesic medicine.